FDA Approves Safer Seldane Developed By Georgetown Pharmacologist
The FDA has approved fexofenadine, a new antihistamine that effectively relieves seasonal allergy symptoms without the risk of fatal heart conditions. Developed by Georgetown pharmacologist Raymond Woosley, fexofenadine was discovered through research on Seldane's cardiac side effects.